Announcements Trials

Browse Landscape

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 28 Carcinoma, Renal Cell 19 Carcinoma, Non-Small-Cell Lung 13 Carcinoma, Hepatocellular 10 Brain Neoplasms 7 Skin Neoplasms 6 Neoplasm Metastasis 6 Clear-cell metastatic renal cell carcinoma 6 Neoplasms 5 Kidney Neoplasms 5 Colorectal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Lung Neoplasms 4 Carcinoma, Transitional Cell 4 Triple Negative Breast Neoplasms 3 Multiple Myeloma 3 Mesothelioma 3 Liver Neoplasms 3 Breast Neoplasms 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Glioblastoma 2 Colonic Neoplasms 2

Interventions

Exercise 36 Nutritional Status 5 Control Groups 4 Resistance Training 3 High-Intensity Interval Training 3 lime 2 Vitamin D 2 Standard of Care 2 Preoperative Exercise 2 Dosage Forms 2 Diet 2 tislelizumab 1 pembrolizumab 1 oncomodulin 1 diacetamate 1 blueberry extract 1 beta-Glucans 1 Whey Proteins 1 Wearable Electronic Devices 1 Walking 1 Transcranial Direct Current Stimulation 1 Tea 1 Tablets 1 TEMPO 1 Spermine Synthase 1 Roflumilast 1 Rehabilitation 1 Radiotherapy 1 Probiotics 1 Physical Therapy Modalities 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Motor Activity × Ipilimumab × Clear all

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡